Merkel cell carcinoma: A case report with treatment summary and updates

Cutis

Volumn 74, Issue 6, 2004, Pages 350-356

  Boyse, Kathryn ^a   Foley, Elizabeth H ^b   Bradley, Valentina ^b   Scarborough, Dwight ^b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b Affiliated Dermatology   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE;

AGED; ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; HISTOPATHOLOGY; HUMAN; MALE; MEDICAL EXAMINATION; MERKEL CELL TUMOR; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PALLIATIVE CARE; SKIN NEOPLASMS;

EID: 12344309520     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nghiem P, McKee PH, Haynes HA. Merkel cell (cutaneous neuroendocrine) carcinoma. In: Sober AJ, Haluska FG, eds. Skin Cancer. Hamilton, Ontario: BC Decker Inc; 2001;127-141.
2. Nathu RM, Mendenhall WM, Parsons JT. Merkel cell carcinoma of the skin. Radiat Oncol Investig. 1998;6:233-239.
3. Halata Z, Grim M, Bauman KI. Friedrich Sigmund Merkel and his "Merkel cell", morphology, development, and physiology: review and new results. Anat Rec. 2003;271A:225-239.
4. Kokoska E, Kokaska M, Collins B, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg. 1997;174:688-692.
5. Krasagakis K, Tosca AD. Overview of Merkel cell carcinoma and recent advances in research. Int J Dermatol. 2003;42:669-676.
6. Rodrigues L, Leong S, Kashani-Sabet M, et al. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol. 2001;45:303-308.
7. Hitchcock CL, Bland KI, Laney RG 3rd, et al. Neuroendocrine (Merkel cell) carcinoma of the skin. its natural history, diagnosis and treatment. Ann Surg. 1988;207:201-207.
8. Kurokawa M, Nabeshima K, Akiyama Y, et al. CD56: a useful marker for diagnosing Merkel cell carcinoma. J Dermatol Sci. 2003;31:219-224.
9. Mortier L, Mirabel X, Fournier C, et al. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol. 2003;139:1587-1590.
10. Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer. 1997;80:881-885.
11. Voog E, Biron P, Martin J, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Am Cancer Soc. 1999;85:2590-2595.
12. Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47:885-892.
13. Mehrany K, Otley CC, Weenig RH, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg. 2002;28:113-117.
14. Hill ADK, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg. 1999;86:518-521.
15. Brady MS. Current management of patients with Merkel cell carcinoma. Dermatol Surg. 2004;30:321-325.
16. Moll I, Kuhn C, Moll R. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J Invest Dermatol. 1995;104:900-915.
17. Durani BK, Klein A, Henze M, et al. Somatostatin analogue scintigraphy in Merkel cell tumours. Br J Dermatol. 2003;148:1135-1140.